✦ LIBER ✦

15LBA Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)

✍ Scribed by R. Adams; R. Wilson; M.T. Seymour; A.M. Meade; A. Madi; J. Cassidy; D. Fisher; S. Kenny; R. Kaplan; T.S. Maughan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6LBA Addition of cetuximab to oxaliplati

✍ T. Maughan; R.A. Adams; C.G. Smith; M.T. Seymour; R. Wilson; A.M. Meade; D. Fish 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Intermittent versus continuous oxaliplat

✍ Richard A Adams; Angela M Meade; Matthew T Seymour; Richard H Wilson; Ayman Madi 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 420 KB

Addition of cetuximab to oxaliplatin-bas

✍ Timothy S Maughan; Richard A Adams; Christopher G Smith; Angela M Meade; Matthew 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 364 KB

Sequential versus combination chemothera

✍ Miriam Koopman; Ninja F Antonini; Joep Douma; Jaap Wals; Aafke H Honkoop; Frans 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 149 KB

Intermittent chemotherapy plus either in

✍ Wasan, Harpreet; Meade, Angela M; Adams, Richard; Wilson, Richard; Pugh, Cheryl; 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 442 KB

6006 ORAL Intermittent Chemotherapy (CT)

✍ Wasan, H.; Adams, R.A.; Wilson, R.H.; Pugh, C.A.; Fisher, D.; Madi, A.; Sizer, B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB